戻る Agenda
Session 3 Track A - Regulatory Leadership: The Importance of a Timely and Efficient Regulatory System and a Proposed Path for Success
Session Chair(s)
Rocelyn DelCarmen
Director, Regulatory Affairs and Quality Assurance
Astrazeneca Canada Inc., Canada
To enable new innovations to be readily available to Canadians, a timely and efficient regulatory system is supportive. During this session, speakers from Industry and Regulatory Authorities will discuss this and offer proposals for the Canadian system to further enhance its effectiveness.
Speaker(s)
Enhancing the Regulatory Approval Process Through Timeliness, Efficiency, and Predictability
Keith McIntosh
Innovative Medicines Canada, Canada
Executive Director, Scientific & Regulatory Affairs
Impact of Time to Drug Approval on Potential Years of Life Lost and The Compelling Need for Improved Trial and Regulatory Efficiency
David J. Stewart, MD, FRCPC
University of Ottawa/The Ottawa Hospital, Canada
Head, Division of Medical Oncology
John-Peter Bradford
Life-Saving Therapies Network, Canada
Executive Director
With Co-presenter Maxine Yu: Finding Efficiencies, Continuous Improvement, Keeping up with Change
Martin McLean
Health Canada, Canada
Regulatory Project Manager, Therapeutic Products Directorate, HPFB
Maxine Yu
Health Canada, Canada
Regulatory Project Manager, Health Products and Food Branch